BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 16009893)

  • 1. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of Alzheimer's disease with a total score of the German CERAD.
    Ehrensperger MM; Berres M; Taylor KI; Monsch AU
    J Int Neuropsychol Soc; 2010 Sep; 16(5):910-20. PubMed ID: 20682088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
    Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
    J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor structure of the CERAD neuropsychological battery.
    Strauss ME; Fritsch T
    J Int Neuropsychol Soc; 2004 Jul; 10(4):559-65. PubMed ID: 15327734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
    Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the Memory Performance Index: reducing measurement error in recall tests.
    Shankle WR; Mangrola T; Chan T; Hara J
    Alzheimers Dement; 2009 Jul; 5(4):295-306. PubMed ID: 19560100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
    Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Severe Cognitive Impairment Rating Scale--an instrument for the assessment of cognition in moderate to severe dementia patients.
    Choe JY; Youn JC; Park JH; Park IS; Jeong JW; Lee WH; Lee SB; Park YS; Jhoo JH; Lee DY; Kim KW
    Dement Geriatr Cogn Disord; 2008; 25(4):321-8. PubMed ID: 18319591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease.
    Berres M; Monsch AU; Bernasconi F; Thalmann B; Stähelin HB
    Stud Health Technol Inform; 2000; 77():195-9. PubMed ID: 11187541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
    Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
    Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.